Not applicableStudy completedNCT03310736What this trial is testingSerum Hepcidin Immunoassay - Laboratory to MarketplaceWho this might be right forAnemia, Iron Deficiency Intrinsic LifeSciences, LLC 494
Testing effectiveness (Phase 2)Study completedNCT03637556What this trial is testingPilot Study to Assess the Safety, PK and Iron Chelating Activity of DST-0509 (Deferasirox) in Thalassemia Patients Refractory to ChelationWho this might be right forThalassemia Major DisperSol Technologies, LLC 25
Testing effectiveness (Phase 2)Study completedNCT01977482What this trial is testingEvaluation of Dose Response Relationship, Safety and Efficacy of GSK1278863 in Hemodialysis-dependent Subjects With Chronic Kidney Disease Associated AnemiaWho this might be right forAnaemia GlaxoSmithKline 216
Testing effectiveness (Phase 2)Study completedNCT00086086What this trial is testingSubcutaneous (SC) Darbepoetin Alfa in Subjects With Symptomatic Congestive Heart Failure (CHF) & AnemiaWho this might be right forCongestive Heart FailureAnemia Amgen 150
Not applicableStudy completedNCT01964742What this trial is testingAnalysis of Host Genetic Factors in the Occurrence of Anemia and on the Virological Response to a Peg-interferon/Ribavirin Therapy in HIV-HCV Co-infected PatientsWho this might be right forHIV-HCV Co-infected Patients Assistance Publique Hopitaux De Marseille 68
Post-approval studies (Phase 4)Study completedNCT01701310What this trial is testingIVICA: Intravenous Iron in Colorectal Cancer Associated AnaemiaWho this might be right forAnemiaColorectal Neoplasm Nottingham University Hospitals NHS Trust 116
Post-approval studies (Phase 4)Ended earlyNCT02624141What this trial is testingRecormon (Epoetin Beta) in Anemic Patients With Non-Myeloid MalignancyWho this might be right forAnemia Hoffmann-La Roche 10
Large-scale testing (Phase 3)Study completedNCT00661999What this trial is testingDarbepoetin Alfa With or Without Iron in Treating Anemia Caused By Chemotherapy in Patients With CancerWho this might be right forAnemiaLeukemiaLymphoma+4 more Mayo Clinic 502
Post-approval studies (Phase 4)Study completedNCT00283465What this trial is testingThe Effectiveness and Safety of Treatment With Epoetin Alfa on Hemoglobin Levels, Red Blood Cell Transfusions, and Quality of Life in Patients With Cancer Receiving Platinum-containing ChemotherapyWho this might be right forAnemiaNeoplasm Janssen-Cilag B.V. 316
Not applicableStudy completedNCT05495607What this trial is testingContinous Renal Replacement Therapy With the CARPEDIEM® in a French National Cohort of 25 Neonates and Small InfantsWho this might be right forHypoxic-Ischemic EncephalopathySepsisKidney Diseases+4 more Centre Hospitalier Universitaire de Nice 25
Testing effectiveness (Phase 2)Study completedNCT00315432What this trial is testingNATURAL HISTORY-Hepatitis C Virus/ Human Immunodeficiency Virus CoinfectionWho this might be right forHepatitis CHIVAnemia Ortho Biotech Products, L.P. 91
Not applicableEnded earlyNCT00952185What this trial is testingInfluenza Vaccine in Preventing Flu in Patients Who Have Undergone Stem Cell Transplant and in Healthy VolunteersWho this might be right forBrain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+7 more City of Hope Medical Center 9
Large-scale testing (Phase 3)UnknownNCT00482716What this trial is testingEpoetin Alfa or Epoetin Beta With or Without Iron Infusion in Treating Anemia in Patients With CancerWho this might be right forAnemiaLeukemiaLymphoma+2 more St. Bartholomew's Hospital 80
Testing effectiveness (Phase 2)Study completedNCT00328549What this trial is testingEvaluate the Erythropoietic Response in Hepatitis C Virus (HCV) Patients Receiving Combination Ribavirin (RBV)/Interferon (IFN) Therapy or RBV/PEG IFN (NATURAL HISTORY-HCV)Who this might be right forHepatitis CAnemia Ortho Biotech Products, L.P. 105
Testing effectiveness (Phase 2)Study completedNCT03041909What this trial is testingAn Extension Study to Further Evaluate the Safety, Tolerability of GBT440 in Patients With Sickle Cell Disease Who Participated in the Study GBT440-001Who this might be right forSickle Cell Disease Global Blood Therapeutics 5
Testing effectiveness (Phase 2)Study completedNCT00388336What this trial is testingPROCRIT (Epoetin Alfa) 60,000 Units Administered Once Every Two Weeks in Anemic Cancer Patients Who Are Not Receiving Chemotherapy or Radiation TherapyWho this might be right forAnemiaNeoplasms Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 57
Large-scale testing (Phase 3)Active Not RecruitingNCT00843882What this trial is testingLenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and AnemiaWho this might be right forAnemiaChronic Myelomonocytic LeukemiaDe Novo Myelodysplastic Syndrome+1 more National Cancer Institute (NCI) 247
Not applicableStudy completedNCT01168349What this trial is testingAn Observational Study of NeoRecormon (Epoetin Beta) in Cancer Patients With Anemia (FAST)Who this might be right forAnemia, Neoplasms Hoffmann-La Roche 1,060
Large-scale testing (Phase 3)Study completedNCT00210587What this trial is testingAn Efficacy and Safety Study for Epoetin Alfa (PROCRIT) in Cancer Patients Not Receiving Chemotherapy or RadiationWho this might be right forAnemiaNeoplasms Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 51
Testing effectiveness (Phase 2)Study completedNCT00360347What this trial is testingMircera in Anemic Patients With Multiple MyelomaWho this might be right forAnemia Hoffmann-La Roche